Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea

First Posted Date
2008-05-01
Last Posted Date
2009-02-19
Lead Sponsor
Yonsei University
Target Recruit Count
200
Registration Number
NCT00669929
Locations
🇰🇷

Wonju Christian Hospital, Wonju, Kangwon-do, Korea, Republic of

🇰🇷

Youngdong Severance Hospital, Seoul, Korea, Republic of

🇰🇷

Yonsei University Health System Severance Hospital, Seoul, Korea, Republic of

S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery

Phase 2
Conditions
First Posted Date
2008-04-16
Last Posted Date
2011-12-06
Lead Sponsor
Yonsei University
Target Recruit Count
32
Registration Number
NCT00659113
Locations
🇰🇷

Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 2
Conditions
First Posted Date
2008-02-29
Last Posted Date
2011-02-28
Lead Sponsor
Yonsei University
Target Recruit Count
46
Registration Number
NCT00625937
Locations
🇰🇷

Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-02-28
Last Posted Date
2012-05-08
Lead Sponsor
Yonsei University
Target Recruit Count
72
Registration Number
NCT00625560
Locations
🇰🇷

Pusan National University School of Medicine, Busan, Korea, Republic of

🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-02-28
Last Posted Date
2012-05-08
Lead Sponsor
Yonsei University
Target Recruit Count
72
Registration Number
NCT00625339
Locations
🇰🇷

Pusan National University School of Medicine, Busan, Korea, Republic of

🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Phase 2
Conditions
First Posted Date
2008-02-15
Last Posted Date
2009-02-09
Lead Sponsor
Yonsei University
Target Recruit Count
35
Registration Number
NCT00616499
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

🇰🇷

Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

and more 1 locations

Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Phase 2
Conditions
First Posted Date
2008-02-15
Last Posted Date
2009-02-09
Lead Sponsor
Yonsei University
Target Recruit Count
41
Registration Number
NCT00616785
Locations
🇰🇷

Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion

First Posted Date
2008-02-11
Last Posted Date
2008-02-11
Lead Sponsor
Yonsei University
Target Recruit Count
40
Registration Number
NCT00612261
Locations
🇰🇷

Yonsei University Health System, Seoul, Korea, Republic of

Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes

First Posted Date
2008-01-18
Last Posted Date
2008-01-18
Lead Sponsor
Yonsei University
Target Recruit Count
83
Registration Number
NCT00598013
Locations
🇰🇷

Yonsei University College of Medicine, Seoul, Korea, Republic of

Corneal Thinning During Topical Bevacizumab Therapy

Not Applicable
Withdrawn
Conditions
First Posted Date
2007-08-14
Last Posted Date
2015-05-01
Lead Sponsor
Yonsei University
Registration Number
NCT00515684
Locations
🇰🇷

Severance hospital, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath